4.7 Article

Prion Infections and Anti-PrP Antibodies Trigger Converging Neurotoxic Pathways

Journal

PLOS PATHOGENS
Volume 11, Issue 2, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1004662

Keywords

-

Funding

  1. European Research Council [ERC: 250356]
  2. European Union [PRIORITY: 222887, NEURINOX: 278611]
  3. Swiss National Foundation [SNF: 31003A_141193, CRSI33_125073, 323530133900]
  4. Novartis Research Foundation
  5. Clinical Research Priority Program (CRPP) of the University of Zurich
  6. Swiss National Science Foundation (SNF) [31003A_141193, CRSI33_125073] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Prions induce lethal neurodegeneration and consist of PrPSc, an aggregated conformer of the cellular prion protein PrPC. Antibody-derived ligands to the globular domain of PrPC (collectively termed GDL) are also neurotoxic. Here we show that GDL and prion infections activate the same pathways. Firstly, both GDL and prion infection of cerebellar organotypic cultured slices (COCS) induced the production of reactive oxygen species (ROS). Accordingly, ROS scavenging, which counteracts GDL toxicity in vitro and in vivo, prolonged the lifespan of prion-infected mice and protected prion-infected COCS from neurodegeneration. Instead, neither glutamate receptor antagonists nor inhibitors of endoplasmic reticulum calcium channels abolished neurotoxicity in either model. Secondly, antibodies against the flexible tail (FT) of PrPC reduced neurotoxicity in both GDL-exposed and prion-infected COCS, suggesting that the FT executes toxicity in both paradigms. Thirdly, the PERK pathway of the unfolded protein response was activated in both models. Finally, 80% of transcriptionally downregulated genes overlapped between prion-infected and GDL-treated COCS. We conclude that GDL mimic the interaction of PrPSc with PrPC, thereby triggering the downstream events characteristic of prion infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available